NES and Miyoshi myopathy: To surmount the existing limitations, future research should focus on validating these approaches in MM and developing innovative therapies, including: developing specific CAR-T cell therapies targeting nestin; and advancing the clinical translation of nestin inhibitors to transcend the constraints of current laboratory-based research.